Recently, the Japanese patent application entitled "A Lithium Battery Production Process and Equipment" filed by Beijing Weilan New Energy Technology Co., Ltd. and the Japanese patent application entitled "Anti-human Interleukin 23 Monoclonal Antibody and Use Thereof" filed by Jiangsu Transcenta Biologics Co., Ltd. have been respectively granted. Among them, "A Lithium Battery Production Process and Equipment" has been granted a Chinese patent, and "Anti-human Interleukin 23 Monoclonal Antibody and Use Thereof" has been granted a Chinese patent and an Australian patent. Beijing Tangsong Yongxin Intellectual Property Agency Co., Ltd. was entrusted by Weilan New Energy and Transcenta Biologics respectively to provide patent legal counsel services throughout the above Japanese patent applications, including contacting foreign associates, responding to Office Actions issued by the Japan Patent Office, etc.